Dr. Howard 'Skip' Burris III Shares His Views on Clinical Trial Eligibility Criteria, Payer Involvement

Q&A with Dr. D. Ross Camidge

Keeping It Personal: CMS-Proposed Coverage Restrictions for NGS Challenge Innovation in Personalized Care

Q&A with TMB Expert Dr. Solange Peters

Q&A with the New IASLC President

An American Perspective on the European Lung Cancer Screening Implementation Plans

Erlotinib, Crizotinib, Nivolumab: Big Three in ALCHEMIST Platform

Commentary Regarding Immune Checkpoint Inhibitors

Q&A with Jamie E. Chaft, MD, Regarding the ALCHEMIST Platform

A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc)

IASLC Leader Elected President of ESMO for 2020–2021: Solange Peters, MD, PhD

Suicide and Lung Cancer: Screening Is Only the First Step